Clinical trial
Randomised Controlled Trial of Vericiguat in Patients With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM)
NCT06239974 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Controlled Trial of Vericiguat in Patients With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM)
- Lead sponsor
- The University of Hong Kong
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 1, 2024
- Completion date
- August 31, 2027
- Enrollment
- 94 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.